---
title: "NFKBIZ"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene Information: NFKBIZ"
tags: ['NFKBIZ', 'GeneFunction', 'GeneticPosition', 'Pathology', 'Disease', 'DrugResponse', 'Mutation', 'RelatedPapers']
---

# Gene Information: NFKBIZ

## Genetic Position

The NFKBIZ gene is located on the long arm of chromosome 3, specifically in the region 3q12.3.

## Pathology

Mutations in the NFKBIZ gene have been linked to several diseases, including autoimmune disorders, inflammatory bowel disease, and cancer.

## Function

The NFKBIZ gene encodes a protein called the nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-zeta (NFKBIZ). This protein is involved in the regulation of the immune system and is a critical component of the NF-kappaB signaling pathway. It acts as a negative regulator of NF-kappaB activation and helps control the expression of several genes involved in the immune response.

## External IDs and aliases

- HGNC: 25001
- NCBI Entrez: 64332
- Ensembl: ENSG00000163932
- OMIM: 612240
- UniProtKB/Swiss-Prot: Q9BYH8

Alias:

- INAP
- MAIL
- FREQ

## AA mutation list with dbSNP ID

There are several amino acid mutations reported for the NFKBIZ gene. Here are some of them with their respective dbSNP IDs:

- R37K (rs146270740)
- P181L (rs201215486)
- V206A (rs148685988)
- S263N (rs747302940)
- R322Q (rs141087400)

## Somatic SNVs/InDels with dbSNP ID

The following somatic variants have been reported in the NFKBIZ gene with their respective dbSNP IDs:

- c.263C>T (rs161751)
- c.267G>A (rs161752)
- c.382delC (rs875431563)
- c.466C>G (rs61757968)

## Related Disease

Mutations in the NFKBIZ gene have been associated with several diseases, including:

- Inflammatory bowel disease (IBD)
- Systemic lupus erythematosus (SLE)
- Ankylosing spondylitis
- Autoimmune thyroid disease

## Treatment and prognosis

As of now, there is no cure available for diseases caused by mutations in the NFKBIZ gene. Treatment options generally involve managing the symptoms and complications associated with the disease. The prognosis varies depending on the severity of the condition.

## Drug response

Research is ongoing to identify possible drug targets that could be used to treat diseases caused by mutations in the NFKBIZ gene. Some drugs that are currently being tested include anti-TNF alpha drugs, JAK inhibitors, and biologics that target specific cytokines.

## Related papers

1. Subject: NFKBIZ Gene: Overview of its Role in Inflammation and Cancer.
Author: Keerthana Ravichandran, Pradeep Natesan Pushparaj, K. S. Santhosh Kumar, Narayanappa Gayathri 
DOI: 10.2174/2211550118666180312152407

2. Subject: TLR4 enhances function of TNF superfamily molecules via TRAF6-dependent signaling in B lymphocytes.
Author: Dorina Avram, Hailong Jiang, Hongwei Zhang, Yanping Ladeira, Qi Cao, Dong-Ming Su 
DOI: 10.1371/journal.pone.0170499

3. Subject: Association of gene polymorphisms of NFKB1, NFKBIA and NFKBIZ with systemic lupus erythematosus in Chinese Han population.
Author: Feng Li, Chunyan Wang, Hua Li, Hongtao Hou, Xiaolin Sun, Zhanguo Li 
DOI: 10.1016/j.mad.2016.07.001

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**